fashion -WSS

fashion

author：entertainment 2025-09-27 10:03:38 - browse：59

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Why rehabilitation engineers need to center patients in their research

hotspot

focus

WSS

Orangutan used medicinal plant to treat wound, first time ever seen

After traumatic brain injury, life support decisions can use more time

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Judge orders hearing on Trump's motion to disqualify Fulton County DA

Element Biosciences CEO lays out genome sequencing strategy

explore

fashion

hotspot

Guidelines to prevent youth baseball injuries need more muscle

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Trump demands the U.S. pay no more for drugs than other countries … again

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Hepatitis C has a cure — but many Americans still lack access to it

Teacher posts viral 'school supply rant' with advice for parents

Novavax promises a turnaround & Lilly roils the obesity market

Q&A: Jennifer Adair on making gene therapy available globally

Malaria cases in Florida and Texas: Here’s what you need to know

Getting Alzheimer's drug Leqembi to patients can be a challenge

knowledge

Orangutan used medicinal plant to treat wound, first time ever seen

H5N1 bird flu virus started spreading in cows in Texas in December

Getting Alzheimer's drug Leqembi to patients can be a challenge

Why does health care cost so much? A reading guide

Many immigrants are left out of maternal health programs

Bird flu in milk supply is likely coming from asymptomatic cows

hotspot

focus

Wikipedia

focus